132 related articles for article (PubMed ID: 15548484)
1. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.
Saft C; Andrich JE; Brune N; Gencik M; Kraus PH; Przuntek H; Epplen JT
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1692-6. PubMed ID: 15548484
[TBL] [Abstract][Full Text] [Related]
2. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
[TBL] [Abstract][Full Text] [Related]
3. Effect of Apolipoprotein E Genotypes on Huntington's Disease Phenotypes in a Han Chinese Population.
Li XY; Zhang YB; Xu M; Cheng HR; Dong Y; Ni W; Li HL; Wu ZY
Neurosci Bull; 2019 Aug; 35(4):756-762. PubMed ID: 30887245
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease.
Panas M; Avramopoulos D; Karadima G; Petersen MB; Vassilopoulos D
J Neurol; 1999 Jul; 246(7):574-7. PubMed ID: 10463359
[TBL] [Abstract][Full Text] [Related]
5. A study of potential interactive genetic factors in Huntington's disease.
Panegyres PK; Beilby J; Bulsara M; Toufexis K; Wong C
Eur Neurol; 2006; 55(4):189-92. PubMed ID: 16772714
[TBL] [Abstract][Full Text] [Related]
6. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease.
Kálmán J; Juhász A; Majtényi K; Rimanóczy A; Jakab K; Gárdián G; Raskó I; Janka Z
Neurobiol Aging; 2000; 21(4):555-8. PubMed ID: 10924769
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
[TBL] [Abstract][Full Text] [Related]
10. Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD; Jankovic J
Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
Feldman B; Chapman J; Korczyn AD
Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
[TBL] [Abstract][Full Text] [Related]
13. Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.
Brune N; Andrich J; Gencik M; Saft C; Müller T; Valentin S; Przuntek H; Epplen JT
J Neural Transm Suppl; 2004; (68):105-10. PubMed ID: 15354395
[TBL] [Abstract][Full Text] [Related]
14. Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
Mol Genet Metab; 2008 Mar; 93(3):341-6. PubMed ID: 18006350
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
Xu EH; Tang Y; Li D; Jia JP
J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
17. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
18. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
[TBL] [Abstract][Full Text] [Related]
19. [Clinical picture of patients with Huntington's disease in relation to the number of trinucleotide CAG repeats in IT-15 gene].
Zielonka D; de Mezer M; Niezgoda A; Reperowicz K; Krzyzosiak W; Kozubski W
Neurol Neurochir Pol; 2002; 36(5):903-9. PubMed ID: 12523115
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.
Nance MA; Mathias-Hagen V; Breningstall G; Wick MJ; McGlennen RC
Neurology; 1999 Jan; 52(2):392-4. PubMed ID: 9932964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
